Aastrom Biosciences Added to Russell Microcap Index
30 juin 2014 08h30 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., June 30, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
Aastrom Announces Initiation of Commercial Sales of Bone Marrow by Marrow Donation, LLC
24 juin 2014 08h45 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., June 24, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business
16 juin 2014 06h00 HE
|
Aastrom Biosciences, Inc.
Manufacturing of MACI in Denmark to be discontinued
Sales of MACI in Europe, representing 1% of revenues in 2014, temporarily ceased
U.S. action plan implemented to optimize R&D,...
Aastrom Announces Investor Conference Call and Webcast June 16, 2014 at 8:30 AM EDT
15 juin 2014 18h00 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., June 15, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
Aastrom Announces Appointment of Gerard Michel as Chief Financial Officer and Vice President, Corporate Development
04 juin 2014 08h45 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., June 4, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
Aastrom Completes Acquisition of Sanofi's Cell Therapy and Regenerative Medicine Business
02 juin 2014 08h45 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., June 2, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
Aastrom Biosciences Reports First-Quarter 2014 Financial Results
15 mai 2014 16h05 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., May 15, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe,...
Aastrom Biosciences to Host First Quarter 2014 Investor Call on May 15, 2014
09 mai 2014 16h05 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., May 9, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe...
Aastrom to Hold Annual Meeting of Shareholders on May 7, 2014
02 mai 2014 16h05 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., May 2, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe,...
Aastrom Announces Definitive Agreement to Acquire Sanofi's Cell Therapy and Regenerative Medicine Business
21 avr. 2014 08h30 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., April 21, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe,...